𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological profile of a novel, orally active leukotriene B4antagonist, SM-15178

✍ Scribed by Naoko Ohmi; Chiemi Tani; Kimiko Yamada; Masaru Fukui

Publisher
Springer
Year
1994
Tongue
English
Weight
598 KB
Volume
18
Category
Article
ISSN
0360-3997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: Synthesis and Pharm
ChemInform Abstract: Synthesis and Pharmacological Profile of New 1,3-Disubstituted Cyclohexanes as Leukotriene B4 Receptor Antagonists.
✍ J. M. POUDREL; P. HULLOT; J. P. VIDAL; J. P. GIRARD; J. C. ROSSI; A. MULLER; C. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 32 KB πŸ‘ 1 views

Synthesis and Pharmacological Profile of New 1,3-Disubstituted Cyclohexanes as Leukotriene B4 Receptor Antagonists. -Novel non-aromatic members of stable leukotriene B4 antagonists such as (VIII) and (IX) are described, in which the conjugated double bond of the natural eicosanoid (X) is replaced b

Investigation on a novel and specific le
Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis
✍ Van Pelt; DE Jong; Seijger; Van Hooijdonk; DE Bakker; Van Vlijmen; Parker; Van E πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 406 KB

The aim of the present study was to investigate the efficacy and clinical tolerability of the specific leukotriene B4 receptor antagonist VML295 in the treatment of stable plaque psoriasis. Immunohistochemical and flow cytometrical methods were used to assess the effects on inflammation and epiderma